Call us free on 0800 862 0373

Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

Breast cancer drug potential to save thousands of lives

Published on 13/12/2013

Women at high risk of developing breast cancer could halve their risk by taking the drug anastrozole, according to a new study.

The drug could change breast cancer prevention methods

According to the study, thousands of high-risk, postmenopausal women significantly reduced their risk of developing the disease by taking anastrozole for five years. The study was led Queen Mary University and funded by Cancer Research UK and the findings were published in The Lancet.

The research involved nearly 4,000 postmenopausal women identified as being at high-risk from developing breast cancer. Half the women were administered with 1mg of anastrozole on a daily basis whilst the other half were given a placebo.

In the five years of study, 40 women on the anastrozole drug and 85 women on the placebo developed breast cancer. Women were deemed high risk of breast cancer if they had a family history of breast cancer, especially those closely related such as a sister or mother. Other factors included women with certain high risk types of benign breast disease.

Professor Jack Cuzick, lead author of the study from Queen Mary University, said: “This research is an exciting development in breast cancer prevention. 

“We now know anastrozole should be the drug of choice when it comes to reducing the risk of breast cancer in postmenopausal women with a family history or other risk factors for the disease.

“This class of drugs is more effective than previous drugs such as tamoxifen and crucially, it has fewer side effects.”

A large number of breast cancers develop due to the hormone oestrogen and anastrozole works by preventing the body from producing oestrogen.

Kate Law, director of research at Cancer Research UK, said: “This landmark study shows that anastrozole could be valuable in helping to prevent breast cancer in women at higher than average risk of disease.

“We now need accurate tests that will predict which women will most benefit from anastrozole and those who will have the fewest side-effects.”

Experts calculate that if the results were extrapolated to all the women in the UK who were at high risk and taking anastrozole then more than 3,200 lives could be saved each year. Cancer Research UK is now campaigning for the National Institute for Health and Care Excellence to approve the drug along with tamoxifen and raloxifene. Both of which were approved earlier this year and help prevent breast cancer developing.

Private health insurance can give you access to ground-breaking new drugs and treatments not always available on the NHS.

© ActiveQuote Ltd. 2013

Categories:  Health InsuranceHealthMedical
Breast cancer drug potential to save thousands of livesWomen at high risk of developing breast cancer could halve their risk by taking the drug anastrozole, according to a new study. The drug c    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile

No.1 health insurance broker as rated by customers

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member

Friendly and efficient. Nothing was too much trouble even when i needed to make a small change, excellent service.

Review centre member

The advisor was incredibly helpful and fully explained the differences between the policies. I really liked the fact that I was put under no pressure.

Review centre member

I was pleasantly surprised with the in-depth knowledge, the efficiency and the nice and polite manner of the staff - the explanations were made very clearly.

Review centre member
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...